These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 378754)

  • 1. Treatment of cirrhosis with colchicine. A double-blind randomized trial.
    Kershenobich D; Uribe M; Suárez GI; Mata JM; Pérez-Tamayo R; Rojkind M
    Gastroenterology; 1979 Sep; 77(3):532-6. PubMed ID: 378754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective trial of colchicine for primary biliary cirrhosis.
    Kaplan MM; Alling DW; Zimmerman HJ; Wolfe HJ; Sepersky RA; Hirsch GS; Elta GH; Glick KA; Eagen KA
    N Engl J Med; 1986 Dec; 315(23):1448-54. PubMed ID: 3537784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of Cpd 861 on chronic hepatitis B related fibrosis and early cirrhosis: a randomized, double blind, placebo controlled clinical trial].
    Yin SS; Wang BE; Wang TL; Jia JD; Qian LX
    Zhonghua Gan Zang Bing Za Zhi; 2004 Aug; 12(8):467-70. PubMed ID: 15329205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine in the treatment of cirrhosis of the liver.
    Kershenobich D; Vargas F; Garcia-Tsao G; Perez Tamayo R; Gent M; Rojkind M
    N Engl J Med; 1988 Jun; 318(26):1709-13. PubMed ID: 3287167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 422():1-340. PubMed ID: 12616289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic efficacy of L-ornithine-L-aspartate infusions in patients with cirrhosis and hepatic encephalopathy: results of a placebo-controlled, double-blind study.
    Kircheis G; Nilius R; Held C; Berndt H; Buchner M; Görtelmeyer R; Hendricks R; Krüger B; Kuklinski B; Meister H; Otto HJ; Rink C; Rösch W; Stauch S
    Hepatology; 1997 Jun; 25(6):1351-60. PubMed ID: 9185752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of patients with primary biliary cirrhosis on colchicine therapy.
    Zifroni A; Schaffner F
    Hepatology; 1991 Dec; 14(6):990-3. PubMed ID: 1959887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Colchicine therapy of fibrosing liver diseases--report of a randomized double-blind study].
    Reinhardt M; Jorke D; Jahn G; Krombholz B; Müller A; Machnik G; Kunath H
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):257-75. PubMed ID: 3542496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. UDCA-PBC Study Group.
    Poupon RE; Huet PM; Poupon R; Bonnand AM; Nhieu JT; Zafrani ES
    Hepatology; 1996 Nov; 24(5):1098-103. PubMed ID: 8903382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of alcoholic hepatitis with colchicine. Results of a randomized double blind trial.
    Trinchet JC; Beaugrand M; Callard P; Hartmann DJ; Gotheil C; Nusgens BV; Lapiere CM; Ferrier JP
    Gastroenterol Clin Biol; 1989 Jun; 13(6-7):551-5. PubMed ID: 2753302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colchicine treatment of liver fibrosis.
    Nikolaidis N; Kountouras J; Giouleme O; Tzarou V; Chatzizisi O; Patsiaoura K; Papageorgiou A; Leontsini M; Eugenidis N; Zamboulis C
    Hepatogastroenterology; 2006; 53(68):281-5. PubMed ID: 16608040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I (IGF-I) replacement therapy increases albumin concentration in liver cirrhosis: results of a pilot randomized controlled clinical trial.
    Conchillo M; de Knegt RJ; Payeras M; Quiroga J; Sangro B; Herrero JI; Castilla-Cortazar I; Frystyk J; Flyvbjerg A; Yoshizawa C; Jansen PL; Scharschmidt B; Prieto J
    J Hepatol; 2005 Oct; 43(4):630-6. PubMed ID: 16024131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis of interleukin-1 beta in primary biliary cirrhosis: relationship to treatment with methotrexate or colchicine and disease progression.
    Miller LC; Sharma A; McKusick AF; Tassoni JP; Dinarello CA; Kaplan MM
    Hepatology; 1995 Aug; 22(2):518-24. PubMed ID: 7635420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NTP technical report on the toxicity studies of Riddelliine (CAS No. 23246-96-0) Administered by Gavage to F344 Rats and B6C3F1 Mice.
    Chan P
    Toxic Rep Ser; 1993 Dec; 27():1-D9. PubMed ID: 12209179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.